Physova · Localise
See where a drug goes, organ by organ
Physova turns virtual patients into organ-scale 3D twins, so you can simulate tissue exposure and drug-device questions that a table of patients cannot answer.
Inhaled SZ-0712 · lung deposition
- Twin anatomies
- 500 (imaging-derived)
- Central airway deposition
- 38% (31–44%)
- Peripheral deposition
- 22% (17–28%)
- Device
- Dry-powder inhaler, 60 L/min
- Render
- Omniverse
Capabilities
What Physova does
Anatomy
Imaging-derived geometry
Clara and MONAI reconstruct organ geometry from imaging to shape each twin.
Exposure
Tissue-scale PK
Modulus surrogates estimate drug exposure within organs and tissues.
Devices
Drug-device combinations
Model inhaler deposition, infusion dynamics and implant elution.
Diversity
Many anatomies
Run the same question across hundreds of anatomies, not one average body.
Review
Inspect in 3D
Teams review twins together in Omniverse.
Edge
Site data ingestion
Stream trial-site imaging and sensor data through Holoscan. Planned.
How it works
Inside Physova
Reconstruct
Build anatomy from imaging.
Attach
Link each twin to a Cohorta patient.
Simulate
Run tissue exposure or device physics.
Inspect
Review results in 3D.
Specification
Specification
Items marked planned are in design with pilot partners.
| Item | Detail |
|---|---|
| Organs (first) | Lung, liver, kidney; others planned |
| Inputs | Imaging-derived anatomy, device parameters, Cohorta profiles |
| Outputs | Regional exposure, deposition maps, intervals |
| Rendering | Omniverse; collaborative review planned |
| Edge | Holoscan and IGX ingestion (planned) |
| Status | Research and development |
Place in the loop
Physova in the Sanenza loop
- 01PopulateCohorta
Generates calibrated virtual-patient cohorts for an indication, region or rare subgroup.
- 02SimulateInsilon
Runs the compound across the whole cohort with PK-PD surrogates and biomolecular response.
- 03DesignProtova
Searches dose, cohort, endpoint and sample size, and scores every candidate protocol.
- 04Stress-testVigila
Oversamples rare subgroups to find adverse-event signals before a patient is exposed.
- 05LocalisePhysova
Renders organ-scale twins for tissue exposure and drug-device questions.
- 06ValidateEvidra
Links each prediction to the real outcome and sends recalibration back to every product.
Questions
About Physova
Is Physova a medical device?
No. It is a research and development tool for drug and device developers, not for diagnosing or treating patients.
Which organs are covered?
We plan to start with lung, liver and kidney, chosen with design partners.
Do we need imaging data?
It helps. Without it, twins use reference anatomies, and the report states that limitation.
See Physova in a briefing
We walk your team through Physova on a public example, then discuss where a pilot could test it against outcomes you already know.